It has been known for years by insiders as the “hidden gem” of North Carolina’s life sciences ecosystem. And now, after four ...

Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial ...

Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...

As Ekterly nears the one-year anniversary of its FDA approval, Italy’s Chiesi Group is making moves to acquire the rare ...

Check out the companies making the biggest moves in midday trading: Sandisk , Micron — Memory stocks were trading higher ...

Q1 2026 earnings call: commercialization timeline, EAP traction, service lab progress, cash runway through 2027 & risks.

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...

On the heels of several big buys, Merck still has eyes for M&A—particularly in the oncology, immunology and cardiometabolic ...

India’s pharma and healthcare deal market remains stable in Q1FY26 at 78 transactions worth USD 1.9 billion, even as overall ...

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

Cellenkos®, Inc., a clinical-stage biotechnology company, developing allogeneic, tissue-targeted regulatory T cell (Treg) ...

Events will feature expert perspectives on BI-1808 in ovarian cancer and T‑cell lymphomas, and BI-1206 for the treatment of NHL LUND, SE / ACCESS Newswire / April 29, 2026 / BioInvent International AB ...